Many cancer patients are receiving unexpected bills from out-of-network providers after surgery.
In ‘An American Sickness’, Elisabeth Rosenthal explains why our healthcare costs are out of control and offers practical steps we can take as individuals as well as a blueprint for reforms.
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
How is the practice of “step therapy” affecting patients?
Let’s keep moving forward in 2017 and address health care access issues, including out-of-pocket costs, that are priorities for most Americans.
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
Cancer research stories worth following this winter include an experimental targeted therapy for metastatic triple negative breast cancer and a study on how the financial toxicity of cancer treatment affects physical health and survival.